Medtronic 2024 J.P. Morgan Healthcare Conference

Medtronic presented its strategy and financial outlook at the 42nd J.P. Morgan Healthcare Conference in January 2024. The company highlighted leading positions across large secular growth markets, evolutionary product launches in diabetes, atrial fibrillation, and cardiac rhythm management, and progress on its comprehensive transformation. Management outlined plans for mid-single digit organic revenue growth, operating efficiencies, and strong shareholder returns through improved capital allocation and dividend growth.